Back

Novo to share Wegovy pill and amylin data at EASD 2026

Verifying
  • Novo plans to present Wegovy pill data at EASD 2026.
  • EASD 2026 will include real-world and clinical data from Novo.
  • Novo will also discuss cardiometabolic pipeline and next-generation amylin treatments.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.